Pediatrix Medical Group, Inc. (MD) Valuation — DCF & Advanced Analysis | MarketCI

Navigation

Explore Analysis Investor Relations AI Assistant Compare Screener

Help Pricing Privacy Terms

Navigation

Explore Analysis Investor Relations AI Assistant Compare Screener

Help Pricing Privacy Terms

Pediatrix Medical Group, Inc. (MD) Valuation — DCF & Advanced Analysis | MarketCI | MarketCI

MD

Market Closed

Pediatrix Medical Group, Inc.

NYSEHealthcare Medical - Care Facilities

4.12K employees

CEO: Mark S. Ordan

Founded: 1995

$24.30

+$0.00(+NaN%)

Market Cap

2.00B

Beta

0.70

52W Range

N/A

Dividend Yield

0.00%

Overview Forecasts Fundamental Market Sentiment Valuation Ownership

Comprehensive Valuation

In-depth valuation analysis including DCF scenarios and peer comparisons.

AI Insight: Pediatrix trades below the PERT-weighted fair value of $27.23, implying a 12.7% upside, supported by varied valuation methods including a high-confidence DCF midpoint of $26.17. Strong profitability (5/5) contrasts with low growth (2/5) and high Monte Carlo volatility (CV 122%) indicating elevated risk and significant value dispersion. Downside risk exceeds 50%, reflecting potential price sensitivity to market fluctuations.

Enhanced Football Field Analysis

Loading comprehensive valuation data...

Fetching multi-methodology valuation ranges...

Explore MD

Overview

Key metrics and AI-powered insights

Forecast

Price targets and earnings estimates

Fundamentals

Income, balance sheet and cash flow

Valuation

P/E, DCF and valuation multiples